Effects of Coenzyme Q10 in Early Parkinson Disease

Authors:
  • DODavid Oakes
    David Oakes
  • KKKarl Kieburtz
    Karl Kieburtz
  • MBM. Flint Beal
    M. Flint Beal
  • RHRichard Haas
    Richard Haas
  • SPSandy Plumb
    Sandy Plumb
  • JJJorge L. Juncos
    Jorge L. Juncos
  • JNJohn Nutt
    John Nutt
  • ISIra Shoulson
    Ira Shoulson
  • JCJulie Carter
    Julie Carter
  • JPJoel S Perlmutter
    Joel S Perlmutter

Top Cited Papers
Open Access
Abstract
PARKINSON DISEASE (PD) is a degenerative neurological disorder that is characterized by resting tremor, slowness of movement, and muscular rigidity. Parkinson disease affects approximately 1% of Americans older than 65 years.1 The cardinal pathological features of PD are loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies in neurons in the substantia nigra and extranigral regions of the brain.2,3

This publication has 1 reference indexed in Scilit: